Aurinia Pharmaceuticals Inc (AUPH)
8.35
+0.08
(+0.97%)
USD |
NASDAQ |
Sep 22, 16:00
8.34
-0.01
(-0.12%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Financing (TTM): 3.467M for June 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 3.467M |
March 31, 2023 | 3.667M |
December 31, 2022 | 2.433M |
September 30, 2022 | 207.47M |
June 30, 2022 | 216.55M |
March 31, 2022 | 216.49M |
December 31, 2021 | 221.11M |
September 30, 2021 | 16.63M |
June 30, 2021 | 196.81M |
March 31, 2021 | 196.48M |
December 31, 2020 | 194.38M |
September 30, 2020 | 390.05M |
June 30, 2020 | 215.64M |
March 31, 2020 | 215.12M |
December 31, 2019 | 243.85M |
September 30, 2019 | 47.55M |
June 30, 2019 | 32.71M |
March 31, 2019 | 35.66M |
December 31, 2018 | 4.014M |
September 30, 2018 | 3.457M |
June 30, 2018 | 4.692M |
March 31, 2018 | 2.972M |
December 31, 2017 | 175.15M |
September 30, 2017 | 203.64M |
June 30, 2017 | 209.83M |
Date | Value |
---|---|
March 31, 2017 | 214.80M |
December 31, 2016 | 42.62M |
September 30, 2016 | 14.08M |
June 30, 2016 | 6.696M |
March 31, 2016 | 0.47M |
December 31, 2015 | 0.839M |
September 30, 2015 | 1.381M |
June 30, 2015 | 1.802M |
March 31, 2015 | 1.422M |
December 31, 2014 | 47.89M |
September 30, 2014 | 47.34M |
June 30, 2014 | 52.39M |
March 31, 2014 | 53.22M |
December 31, 2013 | 6.375M |
September 30, 2013 | 7.131M |
June 30, 2013 | 1.592M |
March 31, 2013 | 0.7197M |
December 31, 2012 | 0.7167M |
September 30, 2012 | -0.0084M |
June 30, 2012 | -0.1577M |
March 31, 2012 | -0.1386M |
December 31, 2011 | 2.282M |
September 30, 2011 | 2.324M |
June 30, 2011 | 7.045M |
March 31, 2011 | 7.053M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.433M
Minimum
Dec 2022
390.05M
Maximum
Sep 2020
133.18M
Average
195.43M
Median
Cash from Financing (TTM) Benchmarks
Acasti Pharma Inc | 0.109M |
Edesa Biotech Inc | 4.417M |
Lexaria Bioscience Corp | 1.700M |
Liminal Biosciences Inc | -4.278M |
Xenon Pharmaceuticals Inc | 0.705M |